Actionable news
All posts from Actionable news
Actionable news in PRTA: Prothena Corporation plc,

Stock To Watch: Prothena (PRTA) In Perilous Reversal

Trade-Ideas LLC identified Prothena ( PRTA) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Prothena as such a stock due to the following factors:

  • PRTA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $20.3 million.
  • PRTA has traded 96,407 shares today.
  • PRTA is down 3.1% today.
  • PRTA was up 5.7% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PRTA with the Ticky from Trade-Ideas. See the FREE profile for PRTA NOW at Trade-Ideas More details on PRTA: Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of novel protein immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion in Ireland. Currently there are 7 analysts that rate Prothena a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Prothena has been 502,700 shares per day over the past 30 days. Prothena has a market cap of $1.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.38 and a short float of 18.2% with 8.69 days to cover. Shares are down 36.9% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the...